Company
Institutional investor and one of OncoSil Medical's biggest shareholders
Every investor coverage indicates participated in a round Regal Partners raised.
Companies Regal Partners acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Regal Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Shareholder acceptances are building for Crimson Education's hostile tilt at ASX-listed tutoring firm Kip McGrath, a bid that wobbled when ally Regal Partners sold out; the suitor may lift its offer to 74 cents.
OncoSil Medical has raised $5.6m from three large existing shareholders to fund overseas and domestic launches of its radiation therapy, after winning TGA and FDA clearances for pancreatic and bile duct cancer use.
Roundup of six Australian funding rounds this week: InDebted, Evolt, Restoke.ai, Mary Technology, Matilda and Demtech.ai, with investors, amounts, InDebted's valuation and a secondary component for early backers and staff.
Also Australian FinTech·SmartCompany·Startup Daily·Australian FinTech·Fintech News Australia·Business News Australia